WILL HUMAN-IMMUNODEFICIENCY-VIRUS P24 ANTIGEN SCREENING INCREASE THE SAFETY OF THE BLOOD-SUPPLY AND, IF SO, AT WHAT COST

被引：25

作者：

BUSCH, MP

ALTER, HJ

机构：

[1] IRWIN MEM BLOOD CTR,SCI SERV,SAN FRANCISCO,CA

[2] UNIV CALIF SAN FRANCISCO,DEPT LAB MED,SAN FRANCISCO,CA 94143

[3] NIH,WARREN GRANT MAGNUSON CLIN CTR,DEPT TRANSFUS MED,INFECT DIS SECT,BETHESDA,MD 20892

来源：

TRANSFUSION | 1995年 / 35卷 / 07期

关键词：

D O I：

10.1046/j.1537-2995.1995.35795357872.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：536 / 539

页数：4

共 26 条

[1]

ALLAIN JP, 1986, LANCET, V2, P1233

[2] PREVALENCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 P24 ANTIGEN IN UNITED-STATES BLOOD-DONORS - AN ASSESSMENT OF THE EFFICACY OF TESTING IN DONOR SCREENING [J].

ALTER, HJ ;

EPSTEIN, JS ;

SWENSON, SG ;

VANRADEN, MJ ;

WARD, JW ;

KASLOW, RA ;

MENITOVE, JE ;

KLEIN, HG ;

SANDLER, SG ;

SAYERS, MH ;

HEWLETT, IK ;

CHERNOFF, AI .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (19) :1312-1317

[3] ESTIMATION OF CURRENT HUMAN-IMMUNODEFICIENCY-VIRUS INCIDENCE RATES FROM A CROSS-SECTIONAL SURVEY USING EARLY DIAGNOSTIC-TESTS [J].

BROOKMEYER, R ;

QUINN, TC .

AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 141 (02) :166-172

[4] EPIDEMIOLOGIC BACKGROUND AND LONG-TERM COURSE OF DISEASE IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED BLOOD-DONORS IDENTIFIED BEFORE ROUTINE LABORATORY SCREENING [J].

BUSCH, MP ;

OPERSKALSKI, EA ;

MOSLEY, JW ;

STEVENS, CE ;

SCHIFF, ER ;

KLEINMAN, SH ;

LEE, H ;

LEE, M ;

HARRIS, M ;

KASPER, CK ;

NOWICKI, MJ ;

PIKE, MC ;

STRAM, D ;

ZHOU, Y ;

DIETRICH, SL ;

LUSHER, JM ;

FLETCHER, MA ;

ALEDORT, LM ;

HASSETT, J ;

HILGARTNER, MW ;

TAYLOR, PE ;

DONEGAN, E ;

KOERPER, MA ;

LEWIS, BH ;

GJERSET, GF ;

HOLLINGSWORTH, CG ;

NEMO, GJ ;

HOAK, J ;

ALTER, HJ ;

DALESSIO, DJ ;

GRADY, GF ;

HOLLAND, PV ;

ROSE, NR ;

SEEFF, LB ;

WITTES, J .

TRANSFUSION, 1994, 34 (10) :858-864

[5] SCREENING OF SELECTED MALE BLOOD-DONORS FOR P24 ANTIGEN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].

BUSCH, MP ;

TAYLOR, PE ;

LENES, BA ;

KLEINMAN, SH ;

STUART, M ;

STEVENS, CE ;

TOMASULO, PA ;

ALLAIN, JP ;

HOLLINGSWORTH, CG ;

MOSLEY, JW .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (19) :1308-1312

[6] TIME-COURSE OF DETECTION OF VIRAL AND SEROLOGIC MARKERS PRECEDING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SEROCONVERSION - IMPLICATIONS FOR SCREENING OF BLOOD AND TISSUE DONORS [J].

BUSCH, MP ;

LEE, LLL ;

SATTEN, GA ;

HENRARD, DR ;

FARZADEGAN, H ;

NELSON, KE ;

READ, S ;

DODD, RY ;

PETERSEN, LR .

TRANSFUSION, 1995, 35 (02) :91-97

[7] HIV AND BLOOD-TRANSFUSIONS - FOCUS ON SEROCONVERSION [J].

BUSCH, MP .

VOX SANGUINIS, 1994, 67 :13-18

[8] HIGH TITERS OF CYTOPATHIC VIRUS IN PLASMA OF PATIENTS WITH SYMPTOMATIC PRIMARY HIV-1 INFECTION [J].

CLARK, SJ ;

SAAG, MS ;

DECKER, WD ;

CAMPBELLHILL, S ;

ROBERSON, JL ;

VELDKAMP, PJ ;

KAPPES, JC ;

HAHN, BH ;

SHAW, GM .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) :954-960

[9] UNSUSPECTED PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION IN SERONEGATIVE EMERGENCY DEPARTMENT PATIENTS [J].

CLARK, SJ ;

KELEN, GD ;

HENRARD, DR ;

DAAR, ES ;

CRAIG, S ;

SHAW, GM ;

QUINN, TC .

JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (01) :194-197

[10]

CLEGHORN F, 1994, 2 NATL C HUM RETR RE, P57

← 1 2 3 →